CJC-1295 (no DAC), GHRP-2 10mg (Blend)
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Recently added product dossiers, ordered by publication date.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
Adipotide, also known as FTPP (CKGGRAKDC-GG-D(KLAKLAK)₂), is a synthetic research peptide designed as a targeted proapoptotic compound and binds to prohibitin receptors on the vascular system of adipose tissue.
AHK (Tripeptide-3) is a research peptide that consists of the tripeptide Ala-His-Lys and is studied with respect to its effects on the function of dermal fibroblasts and the regulation of extracellular matrix genes.
AHK-Cu is a research peptide complex composed of Ala-His-Lys, bound to copper(II), and its role in remodeling the extracellular matrix and activation of fibroblasts is being investigated.
AICAR is a research compound (5-Aminoimidazole-4-carboxamide ribonucleotide) that acts as an AMP analogue and activates the AMP-activated protein kinase (AMPK).
AOD-9604 is a research peptide derived from amino acids 177–191 of the sequence of human growth hormone.
ARA-290 is a synthetic research peptide developed from the B-helix domain region of erythropoietin.
B7-33 is a single-chain peptide analog of the Relaxin family, derived from human H2-relaxin, and aims to selectively activate the RXFP1 receptor without engaging RXFP2.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
The combination of BPC-157 and TB-500 combines two well-characterized research peptides that have been studied with respect to their roles in cellular repair, angiogenesis, and tissue remodeling.
BPC-157 and TB-500 is a research peptide mixture consisting of two cytoprotective peptides, and whose influence on angiogenic and cytoskeletal signals is being studied.
The combination of BPC-157 and TB-500 combines two well-characterized research peptides that have been studied with respect to their roles in cellular repair, angiogenesis, and tissue remodeling.
The Glow Blend combines three research peptides, BPC-157, TB-500, and GHK-Cu, formulated for studies on cellular repair, angiogenesis, and regulation of the extracellular matrix.
BPC-157 5mg, TB-500 (Thymosin Beta-4) 5mg, GHK-Cu 20mg (30mg Total Glow Blend) Click here BPC-157, TB-500, GHK-Cu (Glow Blend) 60mg Mechanisms and Synergy BPC-157: A stable gastric pentadecapeptide that has been shown to accelerate angiogenesis, fibroblast migration, and epithelial repair by modulating the VEGFR2- and FAK-Paxillin pathways and nitric oxide signaling.
BPC-157 10mg, TB-500 (Thymosin Beta-4) 10mg, GHK-Cu 40mg (60mg Total Glow Blend) Click here BPC-157, TB-500, GHK-Cu (Glow Blend) 30mg Mechanisms and Synergy BPC-157: A stable gastric pentadecapeptide that has been shown to accelerate angiogenesis, fibroblast migration, and epithelial repair by modulating the VEGFR2- and FAK-Paxillin pathways and nitric oxide signaling.
The Klow Blend combines four research peptides, BPC-157, TB-500, KPV, and GHK-Cu, that are formulated for studies on cellular repair, immunomodulation, and regulation of the extracellular matrix.
Bronchogen is a peptide bioregulator derived from bronchial tissue extracts, and its influence on the regeneration of the respiratory epithelium as well as the gene expression of alveolar cells is studied.
Cardiogen is a peptide bioregulator derived from heart tissue extracts and composed of short amino acid chains that regulate gene expression in the myocardium and the synthesis of contractile proteins.
Cartalax is a peptide bioregulator complex that was isolated from cartilage tissue, and whose role in the synthesis of the extracellular matrix as well as the gene expression of chondrocytes is being studied.
Chonluten is a synthetic peptide bioregulator derived from lung tissue extracts and composed of short amino acid sequences that modulate respiratory gene expression and oxidative reactions.
CJC-1295 (no DAC) and GHRP-2 is a research peptide mixture designed to investigate the synergistic stimulation of the growth hormone axis through two receptor pathways.
CJC-1295 (without DAC) and GHRP-6 is a research peptide mixture that combines GHRH and ghrelin receptor agonists to produce a synergistic stimulation of the GH axis.
CJC-1295 (without DAC) and Hexarelin are a research peptide mixture that combines GHRH receptor and ghrelin receptor agonists to model growth hormone signaling.
CJC-1295 (without DAC) and Ipamorelin are a research peptide mixture that combines two mechanistically distinct secretagogues that act synergistically on the growth hormone axis.
CJC-1295 (without DAC), Ipamorelin and GHRP-2 is a research peptide mixture that has been formulated to investigate synergistic mechanisms of growth hormone release through dual receptor activation.
CJC-1295 (without DAC) (Modified GRF) is a research peptide, also known as Mod GRF (1–29), a tetra-substituted analogue of the growth hormone-releasing hormone (GHRH 1–29), developed for improved stability and receptor affinity, without DAC conjugation.
CJC-1295 (non-DAC), also known as Mod GRF (1–29), is a tetra-substituted analog of the growth hormone-releasing hormone (GHRH 1–29) developed to improve metabolic stability and receptor affinity without DAC conjugation.
CJC-1295 (no DAC), also known as Mod GRF (1-29), is a tetra-substituted analogue of the growth hormone-releasing hormone (GHRH 1-29) developed for improved stability and receptor affinity without modification of the Drug-Affinity-Complex (DAC).
Cortagen is a peptide bioregulator derived from extracts of the cerebral cortex and studied for its role in neuroprotection and neuronal differentiation.
Jump between recent updates, category pages, and in-depth research guides.
See what's changed: updated product dossiers and long-form research guides in one feed.
Browse compounds grouped by function: secretagogues, modulators, nootropics, and more.
In-depth articles on peptide mechanisms, storage protocols, and preclinical evidence.
Latest changes across products and guides.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Everything about the Wolverine Stack — the popular BPC-157 and TB-500 peptide combination used for accelerated recovery. Protocols, dosing, timing, and what users report.
Everything you need to know about BPC-157 — the gastric pentadecapeptide studied for gut healing, tendon repair, and tissue recovery. Mechanisms, research, safety, and practical considerations.
A detailed comparison of BPC-157 and TB-500 (Thymosin Beta-4) — two of the most researched healing peptides. Mechanisms, benefits, stacking, and which one is right for your situation.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Jump into high-density parts of the catalog.
55 research compounds
21 research compounds
20 research compounds
15 research compounds
13 research compounds
10 research compounds
5 research compounds
4 research compounds